PSI Advisors LLC and other firms reduced their positions in UnitedHealth Group, impacting the stock price negatively.
Stock AI’s forecasts:
🔴 -12.4% short-term ⬇️
🔴 -5.0% long-term ⬇️
Stock AI’s (UNH) Forecast get (+15.7% Profit)
StockAI’s analysis delivers real-world results. On 05 April 2024, $UNH ($455.2), StockAI predicted a long-term 🟢 buy signal. It was accurate: 1 month later price increased to $526.6 (🟢15.7%). Buying UNH on this signal yielded a +15.7% profit 💰💰.
UNH-UnitedHealth Group Incorporated News
🔴 PSI Advisors LLC lowered its position in UnitedHealth Group Incorporated by 20.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC.
🔴 Vicus Capital lowered its holdings in UnitedHealth Group Incorporated by 75.3% in the fourth quarter, according to its most recent 13F filing.
🔴 StockNews.com cut shares of UnitedHealth Group from a buy rating to a hold rating in a research note released on Thursday.
🟢 UnitedHealth Group’s share price rose 3.8% during trading on Thursday after Deutsche Bank raised their price target on the stock.
🟢 UnitedHealth Group had its price target lifted by analysts at Deutsche Bank from $545.00 to $562.00 in a research report issued on Friday.
🔴 Faruqi & Faruqi, LLP is investigating potential claims against UnitedHealth Group Incorporated and reminds investors of the July 15, 2024 deadline.
UnitedHealth Group Incorporated stock has seen a mix of negative and positive news recently. The decrease in positions by PSI Advisors LLC and Vicus Capital, as well as the downgrade by StockNews.com, have put downward pressure on the stock. However, the price target increases by Deutsche Bank and positive trading on Thursday have provided some support. It is important for investors to monitor these developments closely to gauge the overall impact on the stock price in the short and long term.
UNH-UnitedHealth Group Incorporated Analyst Ratings
📉 StockNews.com upgraded UnitedHealth Group (NYSE:UNH) from a hold rating to a buy rating in a recent report.
📈 Barclays raised their price target on UnitedHealth Group (NYSE:UNH) from $534.00 to $560.00.
📉 Zacks Research lowered their Q2 2024 EPS estimates for UnitedHealth Group (NYSE:UNH).
📈 Piper Sandler increased their price objective on UnitedHealth Group (NYSE:UNH) from $566.00 to $571.00.
📈 Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group (NYSE:UNH) from $545.00 to $562.00.
Sources:
1. ETF Daily News
2. ETF Daily News
3. ETF Daily News
4. ETF Daily News
5. ETF Daily News
Disclaimer
Investors may consider the AI predictions and news summaries as one factor in their investment decisions alongside their own research and risk tolerance.
Ready to analyze your own portfolio?
Get the same AI-powered insights for any stock you choose. It's easy!
